Literature DB >> 7105021

Phase I and pharmacological studies of adriamycin administered intraperitoneally to patients with ovarian cancer.

R F Ozols, R C Young, J L Speyer, P H Sugarbaker, R Greene, J Jenkins, C E Myers.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7105021

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  38 in total

1.  Pharmacokinetics of VM 26 given intrapericardially or intravenously in patients with malignant pericardial effusion.

Authors:  F Figoli; M L Zanette; U Tirelli; R Sorio; C Lestuzzi; R Urso; S Monfardini; M D'Incalci
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Intracavitary chemotherapy in ovarian cancer-an investigational procedure.

Authors:  R F Ozols
Journal:  West J Med       Date:  1985-03

3.  Cancer chemotherapeutics as immunomodulators.

Authors:  F Spreafico; A Vecchi; F Colotta; A Montovani
Journal:  Springer Semin Immunopathol       Date:  1985

4.  Preliminary observations of intraperitoneal carboplatin pharmacokinetics during a phase I study of the Northern California Oncology Group.

Authors:  M W DeGregorio; B L Lum; W M Holleran; B J Wilbur; B I Sikic
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

Review 5.  Intraperitoneal drug delivery of antineoplastics.

Authors:  M Markman
Journal:  Drugs       Date:  2001       Impact factor: 9.546

Review 6.  Chemotherapy in advanced ovarian cancer.

Authors:  C J Rodenburg; F J Cleton
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

Review 7.  Extravascular use of drug-eluting beads: a promising approach in compartment-based tumor therapy.

Authors:  Simon Binder; Andrew L Lewis; J-Matthias Löhr; Michael Keese
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

8.  Preoperative intraperitoneal chemotherapy for gastric cancer, with special reference to delayed peritoneal complications.

Authors:  W Adachi; S Koike; M Rafique; S Kajikawa; G Kaneko; T Kuroda; F Iida; K Ishii
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

9.  Ultrastructural features of Adriamycin-induced skeletal and cardiac muscle toxicity.

Authors:  J H Doroshow; C Tallent; J E Schechter
Journal:  Am J Pathol       Date:  1985-02       Impact factor: 4.307

10.  Phase I and pharmacokinetic study of high volume intraperitoneal aclacinomycin-A (Aclarubicin).

Authors:  I G Kerr; S Archer; C DeAngelis; S Farrell; S Hanna; J McKee
Journal:  Invest New Drugs       Date:  1987       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.